Transaction #23508 · Form 4 · 0001193805-25-001765
Arcturus Therapeutics Holdings Inc. · Stock award · Employee Stock Option (right to buy)
Arcturus Therapeutics Holdings Inc. · Transacted December 17, 2025 · Filed December 19, 2025
What does this filing report?
An SEC Form 4 filing for Arcturus Therapeutics Holdings Inc. records a stock award involving Employee Stock Option (right to buy) on December 17, 2025. The reported quantity was 175,000. The filing date is December 19, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0001768224
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 175,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 175,000
- Ownership description
- Not reported
- SEC acceptance time
- Dec 19, 2025, 5:21 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Payne Joseph E ↗
President and CEO · Director
CIK 0001727315
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 175,000
- Conversion / exercise price
- 6.52
- Exercise date
- Not reported
- Expiration date
- December 17, 2035
Filing footnotes & remarks
- F1
- Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
- F2
- The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.